Overview
Not Available
Indication
Potassium is used to regulate hypokalemia as a primary condition or secondary to other medical conditions.
Associated Conditions
- Hypokalemia
- Mild Metabolic acidosis
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|
No clinical trials found
No clinical trials found for this drug
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| Hospira, Inc. | 0409-8183 | INTRAVENOUS | 3.93 g in 20 mL | 7/20/2021 | |
| Exela Pharma Sciences, LLC | 51754-2004 | INTRAVENOUS | 200 meq in 100 mL | 11/15/2019 | |
| ICU Medical Inc. | 0990-7965 | INTRAVENOUS | 128 mg in 100 mL | 7/13/2021 | |
| Hospira, Inc. | 0409-3294 | INTRAVENOUS | 196.3 mg in 1 mL | 7/20/2021 | |
| Exela Pharma Sciences, LLC | 51754-2001 | INTRAVENOUS | 3.93 g in 20 mL | 1/7/2016 | |
| Exela Pharma Sciences, LLC | 51754-2005 | INTRAVENOUS | 100 meq in 50 mL | 11/15/2019 | |
| Hospira, Inc. | 0409-3294 | INTRAVENOUS | 196.3 mg in 1 mL | 12/4/2019 | |
| Hospira, Inc. | 0409-8183 | INTRAVENOUS | 3.93 g in 20 mL | 12/4/2019 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| DBL POTASSIUM ACETATE CONCENTRATED INJECTION 2.45 g/5 ml | SIN05868P | INJECTION | 2.45 g/5 ml | 5/21/1991 | |
| NUTRIFLEX® OMEGA PLUS EMULSION FOR INFUSION | SIN15468P | INJECTION, EMULSION | 2.747g/1000ml | 4/23/2018 | |
| AMINOPLASMAL B.BRAUN 10% E SOLUTION FOR INFUSION | SIN15411P | INFUSION, SOLUTION | 2.453g/1000ml | 1/23/2018 | |
| NUTRIFLEX® OMEGA SPECIAL B. BRAUN EMULSION FOR INFUSION | SIN16734P | INJECTION, EMULSION | 3.689g/1000ml | 3/7/2023 | |
| NUTRIFLEX® OMEGA SPECIAL EMULSION FOR INFUSION | SIN15469P | INJECTION, EMULSION | 3.689g/1000ml | 4/23/2018 |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| NUTRIFLEX OMEGA SPECIAL EMULSION FOR INFUSION | N/A | N/A | N/A | 1/11/2012 | |
| NUTRIFLEX OMEGA PLUS EMULSION FOR INFUSION | N/A | N/A | N/A | 1/11/2012 |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| Plasma-Lyte 56 in 5% glucose 1000mL injection bag AHB2574 | 19441 | Medicine | A | 9/30/1991 | |
| DBL POTASSIUM ACETATE 2.45g/5mL (as anhydrous) Injection | 16266 | Medicine | A | 10/8/1991 |
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| HOMEOPATHIC MEDICINE (S#929) DPS 30C | total health centre | 02093707 | Drops - Oral | 30 C / ML | 12/31/1994 |
| LYPHOLYTE MULTI-ELECTROLYTE CONC INJ | lyphomed, division of fujisawa canada inc. | 01944940 | Liquid - Intravenous | 34.5 MG / ML | 12/31/1991 |
| POTASSIUM ACETATE INJECTION USP | omega laboratories limited | 02362597 | Liquid - Intravenous | 39.2 % / W/V | 7/18/2016 |
| POTASSIUM ACETATE | 00780650 | Liquid - Intravenous | 392 MG / ML | 12/31/1988 | |
| GYNOPT | terra botanica products ltd. | 02233333 | Liquid - Oral | 12 X | 6/3/1998 |
| LYPHOLYTE | Pharmaceutical Partners Of Canada Inc | 02139618 | Solution - Intravenous | 690 MG / 20 ML | 8/14/1996 |
| POTASSIUM ACETATE INJ 392MG/ML USP | lyphomed, division of fujisawa canada inc. | 01944894 | Liquid - Intravenous | 392 MG / ML | 12/31/1984 |
| PLASMA-LYTE 56 5% DEXTROSE INJ | baxter corporation | 00260584 | Liquid - Intravenous | 128 MG / 100 ML | 12/31/1990 |
| C-M COMPOSITUM - LIQ | weleda ag heilmittelbetriebe | 02121239 | Liquid - Oral | 6 D / ML | 12/31/1995 |
| POTASSIUM ACETATE INJECTION | fresenius kabi canada ltd | 02139553 | Solution - Intravenous | 392 MG / ML | 12/31/1984 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| No CIMA AEMPS (Spain) approvals found for this drug. | |||||
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.